Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 8/20 | 0.60 |
| ▸ | CCR5 | P51681 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18901807 | 0.90 | CCR2 (0.61) | CCR2CCR5POLBEPHX2AKR1C3 | |
| SCHEMBL18901610 | 0.90 | POLB (0.64) | CCR2CCR5POLB | |
| SCHEMBL18901533 | 0.90 | POLB (0.64) | CCR2CCR5POLB | |
| SCHEMBL18901612 | 0.79 | AKR1C3 (0.57) | CCR2CCR5EPHX2AKR1C3 | |
| SCHEMBL18901526 | 0.78 | CCR2 (0.64) | CCR2CCR5POLBEPHX2KCNH2 | |
| SCHEMBL18901677 | 0.77 | CCR2 (0.56) | CCR2CCR5POLBPIK3CDPIK3CA | |
| SCHEMBL18901614 | 0.77 | CCR2 (0.67) | CCR2CCR5POLB | |
| SCHEMBL18901618 | 0.77 | CCR2 (0.67) | CCR2CCR5POLB | |
| SCHEMBL19337949 | 0.76 | CCR2 (0.63) | CCR2EPHX2KCNH2 | |
| SCHEMBL14100727 | 0.76 | CCR2 (0.63) | CCR2EPHX2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1763351-B9 | 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS | INCYTE HOLDINGS CORP (US) | 2017-05-31 | — | — | EP | disclosed |